Jiangyun Luo

6PUBLICATIONS
30CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Exercise physiologyEnergy generation, conversion and storage (excl. chemical and electrical)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 13, 2026
Endothelial TBK1 Deficiency Inhibits Endothelial-to-Mesenchymal Transition and Atherogenesis Through Suppressing PAK1/ERK1/2 Signaling.

Yujie Pu, Peihua Dong, Lei He

|Jan 30, 2026
DAPK2 Regulates PKM2 Phosphorylation at Threonine 45 to Facilitate Disturbed Flow-Induced Atherosclerosis.

Shuai Guo, Long Xu, Yixin Chen

|Jan 09, 2026
Neratinib, a Clinical Drug Treating Breast Cancer, Protects Against Vascular Inflammation and Atherosclerosis.

Fan-Shun Zhang, Chenyang He, Yanjun Yin

|Jun 22, 2023
Induction of KLF2 by Exercise Activates eNOS to Improve Vasodilatation in Diabetic Mice.

Jiang-Yun Luo, Chak Kwong Cheng, Lingshan Gou

|Jul 28, 2022
Endothelial UCP2 Is a Mechanosensitive Suppressor of Atherosclerosis.

Jiang-Yun Luo, Chak Kwong Cheng, Lei He

|Jun 24, 2022
Activation of AMPK/miR-181b Axis Alleviates Endothelial Dysfunction and Vascular Inflammation in Diabetic Mice.

Chak-Kwong Cheng, Wenbin Shang, Jian Liu

Pageof 1

Frequent Collaborators

3 joint publications

Yu Huang

2 joint publications

Chi-Fai Ng

2 joint publications

Li Wang

1 joint publications

Wai-San Cheang